These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 38628492)

  • 1. Gut microbiota in MAFLD: therapeutic and diagnostic implications.
    Alghamdi W; Mosli M; Alqahtani SA
    Ther Adv Endocrinol Metab; 2024; 15():20420188241242937. PubMed ID: 38628492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota.
    Cai T; Song X; Xu X; Dong L; Liang S; Xin M; Huang Y; Zhu L; Li T; Wang X; Fang Y; Xu Z; Wang C; Wang M; Li J; Zheng Y; Sun W; Li L
    Front Cell Infect Microbiol; 2024; 14():1323261. PubMed ID: 38444539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation.
    Abenavoli L; Gambardella ML; Scarlata GGM; Lenci I; Baiocchi L; Luzza F
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk.
    Yang K; Song M
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease.
    Dongoran RA; Tu FC; Liu CH
    Tzu Chi Med J; 2023; 35(4):290-299. PubMed ID: 38035056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiome and Ferroptosis in MAFLD.
    Ji J; Wu L; Wei J; Wu J; Guo C
    J Clin Transl Hepatol; 2023 Feb; 11(1):174-187. PubMed ID: 36406312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
    Lanthier N; Delzenne N
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease.
    Wang YY; Lin HL; Wang KL; Que GX; Cao T; Zhu LM; Yang X; Yang XF
    Chin Med Sci J; 2023 Dec; 38(4):286-296. PubMed ID: 38097345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease.
    Bellanti F; Lo Buglio A; Vendemiale G
    Metabolites; 2023 Feb; 13(3):. PubMed ID: 36984762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus.
    Bhardwaj M; Mazumder PM
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; ():. PubMed ID: 38861011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study.
    Tateda T; Iino C; Sasada T; Sato S; Igarashi G; Kawaguchi S; Mikami K; Endo T; Sawada K; Mikami T; Fukuda S; Nakaji S; Sakuraba H
    PLoS One; 2022; 17(11):e0277930. PubMed ID: 36417462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies.
    Maestri M; Santopaolo F; Pompili M; Gasbarrini A; Ponziani FR
    Front Nutr; 2023; 10():1110536. PubMed ID: 36875849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians:
    Yuan H; Wu X; Wang X; Zhou JY; Park S
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging trends and hotspots in the links between the gut microbiota and MAFLD from 2002 to 2021: A bibliometric analysis.
    Li Y; Zhou Y; Wang L; Lin X; Mao M; Yin S; Zhu L; Jiao Y; Yu W; Gao P; Yang L
    Front Endocrinol (Lausanne); 2022; 13():990953. PubMed ID: 36329894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.
    Niu C; Tu Y; Jin Q; Chen Z; Yuan K; Wang M; Zhang P; Luo J; Li H; Yang Y; Liu X; Mao M; Dong T; Tan W; Hu X; Pan Y; Hou L; Ma R; Huang Z
    Front Cell Infect Microbiol; 2023; 13():1157368. PubMed ID: 37180439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oroxin B improves metabolic-associated fatty liver disease by alleviating gut microbiota dysbiosis in a high-fat diet-induced rat model.
    Huang Y; Wang C; Wang M; Xiong T; Song X; Sun W; Li J
    Eur J Pharmacol; 2023 Jul; 951():175788. PubMed ID: 37179040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice.
    Kang K; Sun Y; Pan D; Sang LX; Sun MJ; Li YL; Chang B
    Exp Ther Med; 2021 May; 21(5):418. PubMed ID: 33777186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD).
    Guo Q; Li Y; Dai X; Wang B; Zhang J; Cao H
    Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children.
    Ji J; Sun J; Li J; Xie J; Xi B; Zhao M
    Clin Nutr; 2024 Jan; 43(1):187-196. PubMed ID: 38070210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.